Please login to the form below
Diurnal
This page shows the latest Diurnal news and features for those working in and with pharma, biotech and healthcare.
Diurnal files adrenal insufficiency drug Alkindi in US
Could become only treatment for children with the condition. UK specialty drugmaker Diurnal has filed its Alkindi Sprinkle replacement therapy for children with adrenal insufficiency in the US, a group with ... Diurnal said the US marketing application
Latest news
-
Resurgent Diurnal raises £5.4m for twin product filings
Diurnal is recovering from a tricky period after Chronocort failed to meet its primary objective in a pivotal CAH study, sending its share price into freefall last October. ... Diurnal estimates that the EU market for CAH therapies is worth around $300m.
-
Ashfield to establish European MSL network for Diurnal's Infacort
Ashfield Commercial and Medical Services has been selected by hormone diseases specialist Diurnal to support the launch of its first product, Infacort (hydrocortisone). ... Mark Gibson, director of international business at Ashfield, said: “We are
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Weekly industry appointments
Advanced Medical Solutions and Diurnal Group.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
